Litigation Details for Arbutus Biopharma Corporation v. Moderna, Inc. (D. Del. 2022)
✉ Email this page to a colleague
Arbutus Biopharma Corporation v. Moderna, Inc. (D. Del. 2022)
Docket | ⤷ Try a Trial | Date Filed | 2022-02-28 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:1 Patent Infringement | Assigned To | Mitchell S. Goldberg |
Jury Demand | Plaintiff | Referred To | |
Patents | 7,838,504; 8,058,069; 8,158,601; 8,492,359; 8,822,668; 9,000,002; 9,061,003; 9,364,435 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Arbutus Biopharma Corporation v. Moderna, Inc.
Biologic Drugs cited in Arbutus Biopharma Corporation v. Moderna, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Arbutus Biopharma Corporation v. Moderna, Inc. (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2022-02-28 | 1 | Complaint | them. The Asserted Patents are among them: a. U.S. Patent No. 8,058,069, “Lipid Formulations…deliver nucleic acid-based medicines: U.S. Patent Nos. 8,058,069 (Exhibit A), 8,492,359 (Exhibit B), 8,822,668… COUNT 1: INFRINGEMENT OF U.S. PATENT NO. 8,058,069 65. Paragraphs 1 through 64…Arbutus’s U.S. Patent No. 9,404,127 (“the ’127 Patent”), which, like the Asserted Patents, is directed …attempted to invalidate several of the patents before the United States Patent Case 1:22-cv-00252-MSG Document | External link to document |
2023-08-29 | 129 | Claim Construction Chart | the six patents that Plaintiffs have asserted Defendants infringe: U.S. Patent Nos. 8,058,069 (the “’…Petition for Inter Partes Review of U.S. Patent No. 8,058,069, IPR2019-00554 (Jan. 9, 2019) Petitioner…Petition for Inter Partes Review of U.S. Patent No. 8,058,069, IPR2019-00554, Exhibit 1008 (Jan. 2, 2019…Petition for Inter Partes Review of U.S. Patent No. 8,058,069, IPR2019-00554 (Jan. 9, 2019) Petitioner…Petition for Inter Partes Review of U.S. Patent No. 8,058,069, IPR2019-00554, Exhibit 1008, (Jan. 2, 2019 | External link to document |
2023-09-27 | 133 | COUNT 1: INFRINGEMENT OF U.S. PATENT NO. 8,058,069 65. Paragraphs 1 through …attempted to invalidate several of the patents before the United States Patent Case Case 1:22-cv-00252-…Arbutus’s patented technology, including the technology described and claimed in the Asserted Patents. Moderna…The United States Patent and Trademark Office duly and legally issued the ’069 Patent to one of Arbutus…incorporating Arbutus’s patented LNP delivery technology covered by the ’069 Patent, without authority or | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |